+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cisplatin"

From
Gemcitabine Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Gemcitabine Hydrochloride - Global Strategic Business Report

  • Report
  • April 2025
  • 380 Pages
  • Global
From
Lung Cancer Drugs Market Report 2025 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Urothelial Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Urothelial Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Ovarian Cancer Drugs Market Report 2025 - Product Thumbnail Image

Ovarian Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Metastatic Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Bladder Cancer: Epidemiology Forecast to 2033 - Product Thumbnail Image

Bladder Cancer: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 70 Pages
  • Global
From
Cervical Cancer Treatment - A Global Market Overview - Product Thumbnail Image

Cervical Cancer Treatment - A Global Market Overview

  • Report
  • November 2024
  • 250 Pages
  • Global
From
From
From
Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
IMFINZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMFINZI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Loading Indicator

Cisplatin is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It works by damaging the DNA of cancer cells, preventing them from growing and dividing. Cisplatin is often used in combination with other drugs to increase its effectiveness. It is administered intravenously and can cause side effects such as nausea, vomiting, and hair loss. The market for cisplatin in the treatment of lung cancer is highly competitive, with many companies offering their own versions of the drug. Companies such as Bristol-Myers Squibb, Pfizer, and Merck & Co. are all major players in the market. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of the drug. In the market for cisplatin, companies such as Bristol-Myers Squibb, Pfizer, Merck & Co., Teva Pharmaceuticals, and Mylan are all major players. Show Less Read more